Journal rankings · indicator year 2010
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2010
Oncology journal rankings 2010
141 ranked journals · Subfield in Medicine
Oncology has 141 ranked journals in 2010. The median OJR rose 0.08 on 2009 to 1.01, above the world average of 1.00; Q1 starts at OJR 1.54. The top three are CA A Cancer Journal for Clinicians, Cancer Cell, and Nature Medicine.
Ranks and citation indicators: 2010. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2007–2009, the window the 2010 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery531
- Pulmonary and Respiratory Medicine221
- Cardiology and Cardiovascular Medicine190
- Public Health, Environmental and Occupational Health184
- Oncology141
- Epidemiology129
- Infectious Diseases118
- Radiology, Nuclear Medicine and Imaging105
- Psychiatry and Mental health102
- Endocrinology, Diabetes and Metabolism101
- Neurology95
- Physiology95
Show all 42 subfields
- Orthopedics and Sports Medicine72
- Pediatrics, Perinatology and Child Health65
- Ophthalmology60
- Hematology57
- Dermatology56
- Obstetrics and Gynecology43
- Rheumatology43
- Nephrology37
- Reproductive Medicine36
- Pharmacology35
- Complementary and alternative medicine34
- Emergency Medicine31
- Geriatrics and Gerontology26
- Otorhinolaryngology25
- Pathology and Forensic Medicine21
- Rehabilitation18
- Critical Care and Intensive Care Medicine15
- Immunology and Allergy14
- Genetics11
- Hepatology10
- Urology10
- Anesthesiology and Pain Medicine8
- Gastroenterology7
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
141 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2009. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2007–2009, the window the 2010 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2007–2009 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2001 to 2010. | Compare |
|---|---|---|---|---|---|---|---|
1CA A Cancer Journal for CliniciansOAWiley · United States | 40.02Q1 | 104.89 2.25 up from 2009 | 70 | 100% | $4,330 | ||
2Cancer CellCell Press · Netherlands | 7.00Q1 | 18.35 0.09 up from 2009 | 390 | 100% | $10,400 | ||
3Nature MedicineNature Portfolio · United States | 5.80Q1 | 12.13 0.54 down from 2009 | 1,090 | 32% | $12,690 | ||
4Journal of Clinical OncologyLippincott Williams & Wilkins · United States | 5.56Q1 | 14.07 2.11 up from 2009 | 3,361 | 12% | — | ||
5The Lancet OncologyElsevier BV · United Kingdom | 4.85Q1 | 12.68 2.76 up from 2009 | 623 | 15% | $7,280 | ||
6JNCI Journal of the National Cancer InstituteOxford University Press · United States | 4.32Q1 | 11.19 0.05 down from 2009 | 695 | 45% | $5,436 | ||
7The OncologistOAAlphaMed Press · United Kingdom | 3.25Q1 | 6.99 0.78 down from 2009 | 470 | 95% | $3,852 | ||
8Clinical Cancer ResearchAmerican Association for Cancer Research · United States | 3.12Q1 | 8.47 1.31 up from 2009 | 3,163 | 45% | — | ||
9Seminars in Cancer BiologyElsevier BV · United States | 2.90Q1 | 9.09 2.31 up from 2009 | 138 | 35% | $6,060 | ||
10CancerWiley · United States | 2.84Q1 | 6.01 0.13 down from 2009 | 2,219 | 69% | $4,790 | ||
11Clinical Pharmacology & TherapeuticsWiley · United States | 2.75Q1 | 4.91 0.51 down from 2009 | 862 | 15% | $4,410 | ||
12Journal of the National Comprehensive Cancer NetworkNational Comprehensive Cancer | 2.74Q1 | 7.09 3.63 up from 2009 | 167 | 73% | — | ||
13Annals of OncologyElsevier BV · Netherlands | 2.57Q1 | 5.66 0.40 down from 2009 | 1,446 | 93% | $5,080 | ||
14Cancer Prevention ResearchAmerican Association for Cancer Research · United States | 2.37Q1 | 5.30 1.03 up from 2009 | 248 | 21% | — | ||
15Molecular Cancer TherapeuticsAmerican Association for Cancer Research · United States | 2.23Q1 | 6.01 0.27 up from 2009 | 1,116 | 60% | — | ||
16Cancer ControlOASAGE Publishing · United States | 2.15Q1 | 4.53 0.33 up from 2009 | 120 | 33% | $2,650 | ||
17British Journal of CancerSpringer Nature · United Kingdom | 2.14Q1 | 5.64 0.71 up from 2009 | 1,828 | 100% | $5,190 | ||
18Current Opinion in OncologyLippincott Williams & Wilkins · United Kingdom | 2.11Q1 | 5.13 0.51 up from 2009 | 283 | 13% | — | ||
19European Journal of CancerElsevier BV · United Kingdom | 2.08Q1 | 5.56 0.80 up from 2009 | 1,132 | 17% | $4,270 | ||
20JNCI MonographsOxford University Press · United Kingdom | 2.04Q1 | 3.74 0.92 up from 2009 | 33 | 98% | — | ||
21Journal of Mammary Gland Biology and NeoplasiaSpringer Science+Business Media · United States | 2.02Q1 | 4.92 0.49 up from 2009 | 114 | 63% | $4,090 | ||
22Cancer Epidemiology Biomarkers & PreventionAmerican Association for Cancer Research · United States | 2.01Q1 | 4.91 0.20 up from 2009 | 1,451 | 45% | — | ||
23International Journal of CancerWiley · United States | 1.98Q1 | 5.03 0.28 up from 2009 | 2,595 | 69% | $5,030 | ||
24Critical Reviews in Oncology/HematologyElsevier BV · Netherlands | 1.97Q1 | 4.88 0.45 down from 2009 | 320 | 7% | $4,190 | ||
25Expert Opinion on Investigational DrugsTaylor & Francis · United Kingdom | 1.87Q1 | 4.57 0.25 up from 2009 | 508 | 13% | — | ||
26Cancer Treatment ReviewsElsevier BV · United Kingdom | 1.82Q1 | 7.70 1.93 up from 2009 | 247 | 11% | $4,910 | ||
27Clinical & Experimental MetastasisSpringer Science+Business Media · Netherlands | 1.80Q1 | 4.83 0.26 up from 2009 | 243 | 28% | $5,090 | ||
28Hematology/Oncology Clinics of North AmericaElsevier BV · United States | 1.79Q1 | 3.90 0.57 up from 2009 | 227 | 10% | $3,950 | ||
29Seminars in OncologyElsevier BV · United States | 1.77Q1 | 4.27 0.32 up from 2009 | 235 | 18% | $3,550 | ||
30European Journal of EpidemiologySpringer Science+Business Media · Italy | 1.74Q1 | 4.77 0.88 up from 2009 | 327 | 60% | $3,690 | ||
31The Cancer JournalLippincott Williams & Wilkins · United States | 1.71Q1 | 3.89 0.07 up from 2009 | 220 | 16% | — | ||
32Journal of Hematology & OncologyOABioMed Central · United Kingdom | 1.65Q1 | 3.88 1.56 up from 2009 | 78 | 100% | $4,990 | ||
33Diseases of the Colon & RectumLippincott Williams & Wilkins · United States | 1.58Q1 | 3.54 0.12 down from 2009 | 831 | 4% | — | ||
34BMC CancerOABioMed Central · United Kingdom | 1.54Q1 | 4.03 0.44 up from 2009 | 1,095 | 100% | $3,390 | ||
35Psycho-OncologyWiley · United Kingdom | 1.54Q1 | 3.32 0.32 up from 2009 | 469 | 23% | $4,940 | ||
36Current Treatment Options in OncologySpringer Science+Business Media · United States | 1.54Q1 | 3.57 1.00 up from 2009 | 99 | 24% | $4,890 | ||
37Archives of Pathology & Laboratory MedicineOAAmerican Medical Association · United States | 1.46Q2 | 3.09 0.05 up from 2009 | 732 | 5% | — | ||
38Breast Cancer ResearchOABioMed Central · United Kingdom | 1.44Q2 | 3.66 0.35 up from 2009 | 755 | 100% | $4,190 | ||
39Cancer Causes & ControlSpringer Science+Business Media · Netherlands | 1.43Q2 | 3.35 0.04 up from 2009 | 520 | 48% | $3,890 | ||
40Integrative Cancer TherapiesOASAGE Publishing · United States | 1.42Q2 | 2.29 0.02 up from 2009 | 129 | 100% | $2,650 | ||
41MicrocirculationWiley · United States | 1.39Q2 | 3.40 0.62 up from 2009 | 170 | 55% | $3,920 | ||
42JBIC Journal of Biological Inorganic ChemistrySpringer Science+Business Media · Germany | 1.37Q2 | 2.90 0.26 down from 2009 | 407 | 43% | $3,990 | ||
43Journal of ImmunotherapyLippincott Williams & Wilkins · United States | 1.33Q2 | 3.88 0.52 up from 2009 | 279 | 35% | — | ||
44Cancer Immunology ImmunotherapyOASpringer Science+Business Media · Germany | 1.33Q2 | 4.21 0.48 up from 2009 | 521 | 99% | $4,590 | ||
45Expert Review of Anticancer TherapyTaylor & Francis · United Kingdom | 1.33Q2 | 3.30 0.48 up from 2009 | 502 | 26% | — | ||
46Journal of Inorganic BiochemistryElsevier BV · United States | 1.29Q2 | 3.42 0.23 up from 2009 | 661 | 23% | $4,220 | ||
47CytotherapyElsevier BV · United Kingdom | 1.28Q2 | 4.07 1.37 up from 2009 | 293 | 20% | $3,300 | ||
48Cancer NursingLippincott Williams & Wilkins · United States | 1.27Q2 | 2.22 0.25 up from 2009 | 256 | 23% | — | ||
49Oncology nursing forumOncology Nursing Society · United States | 1.25Q2 | 1.83 0.28 down from 2009 | 353 | 9% | — | ||
50Journal of Clinical PathologyBMJ · United Kingdom | 1.25Q2 | 2.61 0.21 down from 2009 | 724 | 18% | — |
Subfields of Medicine, with Oncology highlighted.
- Surgery531
- Pulmonary and Respiratory Medicine221
- Cardiology and Cardiovascular Medicine190
- Public Health, Environmental and Occupational Health184
- Oncology141
- Epidemiology129
- Infectious Diseases118
- Radiology, Nuclear Medicine and Imaging105
- Psychiatry and Mental health102
- Endocrinology, Diabetes and Metabolism101
- Neurology95
- Physiology95
- Orthopedics and Sports Medicine72
- Pediatrics, Perinatology and Child Health65
- Ophthalmology60
- Hematology57
- Dermatology56
- Obstetrics and Gynecology43
- Rheumatology43
- Nephrology37
- Reproductive Medicine36
- Pharmacology35
- Complementary and alternative medicine34
- Emergency Medicine31
- Geriatrics and Gerontology26
- Otorhinolaryngology25
- Pathology and Forensic Medicine21
- Rehabilitation18
- Critical Care and Intensive Care Medicine15
- Immunology and Allergy14
- Genetics11
- Hepatology10
- Urology10
- Anesthesiology and Pain Medicine8
- Gastroenterology7
- Internal Medicine4
- Family Practice2
- Transplantation2
- Biochemistry1
- Anatomy0
- Health Informatics0
- Microbiology0
Journals
Citations made in 2010. Corpus-wide, 73.2% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
50 additional Oncology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2007–2009, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2010. Publication window: 2007–2009. How these summaries are calculated
- Ranked journals
- 141
- Window papers (baseline)
- 77,009 +24.0% from indicator year 2007
- Median OJR
- 1.010 +12.8% from indicator year 2007
- Rising journals (2025)
- 20
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2007–2009 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 82 | 88 | 96 | 103 | 109 | 120 | 120 | 126 | 127 | 134 | 141 | 150 | 153 | 170 | 179 | 188 | 198 | 213 | 224 | 234 | 238 | 239 | 245 | 245 | 243 | 242 | |
| Window papers (baseline) | 37,821 | 41,430 | 44,340 | 47,392 | 49,058 | 53,111 | 57,002 | 62,106 | 66,087 | 71,283 | 77,009 | 82,075 | 86,189 | 88,804 | 93,912 | 98,660 | 102,921 | 105,891 | 109,984 | 115,044 | 121,890 | 139,666 | 156,942 | 167,602 | 163,907 | 160,807 | |
| Median OJR | 0.55 | 0.62 | 0.70 | 0.799 | 0.805 | 0.831 | 0.85 | 0.90 | 0.94 | 0.93 | 1.010 | 0.95 | 1.006 | 0.974 | 0.972 | 0.967 | 0.832 | 0.84 | 0.82 | 0.79 | 0.829 | 0.830 | 0.77 | 0.750 | 0.73 | 0.748 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.